Trump Tariff Impact Global Economic Tracking and Market Implications VIAVI Solutions Unveils CyberFlood CF1000 400G Security Test Platform Targeting HighSpeed Network Security Validation Amgen Pipeline Strength and Rare Disease Momentum Highlighted as Key Growth Drivers UK ZeroHours Contract Ban Gains Momentum as Campaigners Urge Government Action Dell Technologies Shares Reach New 52Week High Amid Analyst Optimism Gold Prices in 2026 Analysts Weigh Potential Rally Amid Global Uncertainty Core Scientific Q1 2026 Earnings Massive EPS Miss Amid Cryptocurrency Mining Headwinds Stock Edges Higher QURE Q1 2026 Earnings Narrower Loss Than Expected but Stock Declines on Lack of Revenue HAYW Q1 2026 Earnings EPS Surprises to the Upside Amidst Quiet Revenue Picture Gogo Inc GOGO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Amid Revenue Disclosure Gap Washington Trust Bancorp Inc WASH Q1 2026 Earnings EPS Misses Estimates Stock Slightly Lower AP Q4 2025 Earnings Net Loss Reported as Company Navigates Challenging Conditions Cognex Corporation CGNX Rallies Over 3 as Shares Bounce From Key Support Horizon Technology Finance HRZN Sees Modest Uptick Holds Above Key Support Gesher Acquisition Corp II Warrants GSHRW Drop 417 as Trading Narrows Between Support and Resistance Perella Weinberg Partners PWP Edges Higher Nears Resistance Amid Steady Momentum Western Asset Intermediate Muni Fund SBI Holds Steady Near 775 as Market Awaits Catalyst European Manufacturers Deepen China Ties Amid EU DeRisking Push BL Q1 2026 Earnings EPS Surpasses Expectations by Over 21 Marvell Technology Gains Momentum MRVL Approaches Key Resistance After 29 Rally HRMY Q1 2026 Earnings EPS Misses Estimates Stock Dips GNLX Q1 2026 Earnings EPS Miss Amid PreRevenue Development Stage Stock Edges Higher TFI International Q1 2026 Earnings EPS Beats Estimates by Over 11 Shares Edge Higher TLK Q4 2025 Earnings EPS Misses Estimations Significantly Stock Declines 472 CVKD Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline DMLP Q4 2024 Earnings Limited Partnership Reports EPS of 024 Amid Steady Operations Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline